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Abstract Most females have random X-chromosome
inactivation (XCI), deWned as an equal likelihood for inacti-
vation of the maternally- or paternally-derived X chromo-
some in each cell. Several X-linked disorders have been
associated with a higher prevalence of non-random XCI
patterns, but previous studies on XCI patterns in Aicardi
syndrome were limited by small numbers and older
methodologies, and have yielded conXicting results. We
studied XCI patterns in DNA extracted from peripheral
blood leukocytes of 35 girls with typical Aicardi syndrome
(AIC) from 0.25 to 16.42 years of age, using the human
androgen receptor assay. Data on 33 informative samples
showed non-random XCI in 11 (33%), deWned as a >80:20%
skewed ratio of one versus the other X chromosome being
active. In six (18%) of these, there was a >95:5% extremely
skewed ratio of one versus the other X chromosome being
active. XCI patterns on maternal samples were not exces-
sively skewed. The prevalence of non-random XCI in
Aicardi syndrome is signiWcantly diVerent from that in the
general population (p < 0.0001) and provides additional
support for the hypothesis that Aicardi syndrome is an
X-linked disorder. We also investigated the correlation
between X-inactivation patterns and clinical severity and
found that non-random XCI is associated with a high neu-
rological composite severity score. Conversely, a statisti-
cally signiWcant association was found between random
XCI and the skeletal composite score. Correlations between
X-inactivation patterns and individual features were made
and we found a signiWcant association between vertebral
anomalies and random XCI.
Introduction
Aicardi syndrome (AIC) is a severe sporadic neurodevelop-
mental disorder, originally characterized by a triad of
agenesis of the corpus callosum, chorioretinal lacunae, and
infantile spasms (Aicardi et al. 1965). More recent studies
have identiWed a broader range of abnormalities with a
wide variability in severity and often asymmetry (Aicardi
1999, 2005). Brain abnormalities seen in Aicardi syndrome
include complete or partial agenesis of the corpus callosum,
periventricular and subcortical heterotopias, polymicrogyria,
microcephaly, ventriculomegaly, arachnoid cysts, cerebral
asymmetry, inferior vermian hypoplasia, dysplastic and
hypoplastic cerebellar hemispheres, enlarged cisterna
magna, choroid plexus papillomas, and other intracranial
cysts (Font et al. 1991; Hopkins et al. 2008; Menezes et al.
1994; Smith et al. 1996). AVected individuals often have
severe infantile spasms that progress with age to complex
T. N. Eble · V. R. Sutton · W. Jin · R. A. Lewis · P. Fang · 
I. B. Van den Veyver
Department of Molecular and Human Genetics, 
Baylor College of Medicine, Houston, Texas, USA
e-mail: teble@bcm.edu
H. Sangi-Haghpeykar · X. Wang · I. B. Van den Veyver (&)
Department of Obstetrics and Gynecology, 
Baylor College of Medicine, 1709 Dryden, 
Suite 1100, Houston, TX 77030, USA
e-mail: iveyver@bcm.edu
R. A. Lewis
Department of Ophthalmology, 
Baylor College of Medicine, Houston, Texas, USA
R. A. Lewis
Department of Medicine, Baylor College of Medicine, 
Houston, Texas, USA
R. A. Lewis
Department of Pediatrics, Baylor College of Medicine, 
Houston, Texas, USA123
212 Hum Genet (2009) 125:211–216seizures of varying types (Glasmacher et al. 2007).
Electroencephalograms (EEG) are often abnormal with
asynchrony between the two hemispheres, burst-suppres-
sion, and atypical hypsarrhythmia (Fariello et al. 1977;
Ohtsuka et al. 1993; Palmer et al. 2006). Ophthalmological
abnormalities are also variable and include unilateral or
bilateral chorioretinal lacunae, optic nerve dysplasia, and
microphthalmia (Aicardi 1999; Denslow and Robb 1979;
Menezes et al. 1996). Other features present in subsets of
aVected individuals are costovertebral anomalies, facial
dysmorphism, hand abnormalities, hypopigmentary skin
lesions, multiple nevi, and an increased occurrence of rare
vascular malformations and tumors (Sutton et al. 2005).
Aicardi syndrome has been reported nearly exclusively
in females. The few known males with AIC have a 47,XXY
karyotype (Hopkins et al. 1979), and reported cases of male
AIC with a 46,XY karyotype have not been conWrmed or
may represent cases with rare mosaic mutations (Chappelow
et al. 2008; Aggarwal et al. 2000; Aicardi 1980; Curatolo
et al. 1980). A longstanding hypothesis is that the condition
is caused by a heterozygous mutation in a gene on the X
chromosome in females that causes lethality when present
in hemizygous males (Van den Veyver 2002). Because AIC
is rare and almost always sporadic, classic linkage analysis
to localize the mutated gene is not possible. The lack of
familial cases, aside from two reported aVected sisters
(Molina et al. 1989), suggests that most mutations are de
novo.
The asymmetry and variability of the phenotype suggest
that the putative gene mutated in AIC is subject to X-chro-
mosome inactivation (Aicardi 2005; Van den Veyver
2002). The presumed male-lethality implies that the gene
must have an important role in development and that
aVected females might show excess non-random XCI pat-
terns. Until the disease-causing mutation is identiWed, the
recognition and documentation of non-random XCI in AIC
would provide additional strong support for the assertion
that it is an X-linked disorder. Previous work has demon-
strated that skewed X-chromosome inactivation is common
in female subjects of families with X-linked mental retarda-
tion (Plenge et al. 2002). However, the evaluation of XCI in
AIC has been limited by the small numbers of subjects
studied and older methodology, and diVerent studies have
generated contradictory results. One investigation, that
evaluated XCI by DNA methylation analysis at the andro-
gen receptor gene in peripheral blood leukocytes of ten
females with AIC and their parents, found that patients had
a random XCI pattern (Hoag et al. 1997). An isolated case
report described a single girl with AIC and random XCI
(Wieacker et al. 1985). In contrast, Neidich et al. observed
a skewed pattern of XCI in three out of seven aVected girls
using methylation-sensitive restriction enzyme analysis
coupled with segregation of the active X chromosome in
somatic cell hybrids (Neidich et al. 1990). In this small
series, three of the Wve most severely aVected girls had non-
random XCI.
To address more deWnitely whether individuals with AIC
have excess skewing of XCI, we performed detailed
clinical assessments and XCI studies in 35 peripheral blood
leukocyte-derived DNA samples from girls with well-
characterized AIC. We further investigated the relationship
between the extent of XCI skewing and the severity of the
phenotype in aVected girls. We show that the fraction of




Individuals with AIC and their parents were enrolled under
a protocol approved by the Baylor College of Medicine
Institutional Review Board for Human Subjects Research.
Informed consent was obtained for all study participants
from the legally authorized representative. The diagnosis of
AIC was conWrmed in all aVected patients based on pheno-
typic data obtained from clinical examinations, ophthalmo-
logical examinations, parental interviews, and from review
of available medical records and imaging studies. The
results were recorded in a secure database, as previously
reported in part (Hopkins et al. 2008; Sutton et al. 2005).
Samples and DNA extraction
DNA samples from 35 females with AIC were analyzed.
For 19 of these, we also sampled DNA from both parents;
for ten, we only had maternal DNA samples, for one we
only had a paternal DNA sample and for Wve we had
neither maternal nor paternal DNA available. All DNA was
extracted using the Puregene DNA extraction kit according
to the manufacturer’s protocol (Gentra Systems, Inc.
Minneapolis, MN) from peripheral blood leukocytes.
X chromosome inactivation assay
We performed the human androgen-receptor X-inactivation
assay as previously described (Allen et al. 1992; Wang
et al. 2007). BrieXy, 100 ng of each female genomic DNA
sample was digested either with the methylation-sensitive
restriction enzyme HpaII (New England Biolabs, Inc.,
Ipswich, MA) or incubated with 1£ enzyme buVer only.
Paternal DNA samples were incubated with 1£ enzyme
buVer only. One nanogram of each was then ampliWed by
PCR with primers Xanking the polymorphic androgen
receptor CAG repeat (Wang et al. 2007). PCR products123
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Prism 3100 Genetic Analyzer and analyzed with GeneMap-
per V3.5 software (Applied Biosystems, Foster City, CA).
The percent X-chromosome inactivation was calculated
with the following formula: percent inactivation = allele
A peak height/(allele A peak height + allele B peak
height) £ 100. We used a cutoV of >80:20% for skewed
XCI and >95:5% for extremely skewed XCI (Allen et al.
1992; Naumova et al. 1996).
Phenotype-XCI correlation
Phenotypic features for each of the individuals with AIC,
gathered from the ophthalmological examination (n = 32),
neuroimaging studies (n = 24), parental interview (n = 27),
and review of medical records (n = 25) were given a
weighted score (Table 1). Composite severity scores (CSS)
for overall severity, neurological, skeletal, and ophthalmo-
logical Wndings were also calculated. Ophthalmological
CSS features include microphthalmia, lacunae, and optic
nerve abnormalities, neurological CSS features include
microgyria, ACC, heterotopias and cysts, skeletal CSS fea-
tures include absent or abnormal ribs and vertebral anoma-
lies and all features were included for the overall CSS. The
severity of individual phenotypes and CSS were compared
between girls with random XCI and girls with non-random
XCI. The correlation between overall CSS and XCI pat-
terns was calculated in two diVerent ways: the Wrst includ-
ing only patients with values for each one of the phenotypes
examined, and the second including all patients with any
phenotypic data, even if there were missing values for some
of the examined phenotypes.
Statistical analysis
Statistical comparison of the groups of interest was made
via X2 or Fisher exact test for grouped data, and Wilcoxon
rank test for ordinal data. Spearman correlation coeYcients
were generated to assess the degree of relationship between
subject’s age and percent XCI. A p value · 0.05 was con-
sidered statistically signiWcant. All analyses were per-
formed with the SAS System statistical software (SAS,
Cary, NC).
Results
The ages of the aVected girls at the time the DNA samples
were obtained ranged from 0.25 to 16.42 years, with a
mean age of 5.12 years and a median age of 4.84 years.
Skewed (>80:20%) XCI was seen in 11 (33%) of the girls,
of whom six (18%) showed extreme skewing (>95:5%)
(Fig. 1a). We compared the prevalence of XCI skewing in
our study population to that in the general population as
reported in Amos-Landgraf et al. 2006 who used the same
>80:20% and >95:5% cut-oVs to deWne XCI skewing and
the same methodology as used in our study. We found that
the prevalence of XCI skewing (p < 0.0001) and of extreme
XCI skewing (p < 0.0001) were both signiWcantly increased
over that reported for the general population.
Only three (9%) of studied mothers had a non-random
XCI pattern. Interestingly, when XCI patterns in mother–
daughter pairs were compared, we found two pairs for
Table 1 Phenotypic scoring system
Phenotypic features of girls with AIC were given a weighted score
relative to their severity or to their unilateral or bilateral presence. All
values were added to calculate an overall composite severity score
(CSS) for each individual
a Values for selected features were added to calculate a neurological
CSS for each individual
b Values for selected features were added to calculate a ophthalmo-
logical CSS for each individual
c Values for selected features were added to calculate a skeletal CSS
for each individual
Phenotypic Feature Finding Score N (%)
Agenesis of the 
Corpus Callosuma 
(N = 33)
No 0 0 (0)
Partial 1 11 (33.3)
Complete 2 22 (66.7)
Infantile Spasms 
(N = 31)
No 0 2 (6.5)
Yes 1 29 (93.5)
Microgyriaa (N = 21) No 0 2 (9.5)
Yes 1 19 (90.5)
Heterotopiasa (N = 22) No 0 3 (13.6)
Yes 1 19 (86.4)
Intracranial Cystsa 
(N = 26)
No 0 4 (15.4)
Yes 1 22 (84.6)
Retinal Lacunaeb 
(N = 31)
No 0 2 (6.5)
Unable to Assess 1 1 (3.2)
Unilateral 2 3 (9.7)
Bilateral 3 25 (80.6)
Microphthalmiab 
(N = 31)
No 0 21 (67.8)
Unilateral 2 9 (29)




No 0 2 (6.5)
Unable to Assess 1 2 (6.5)
Unilateral 2 10 (32.2)
Bilateral 3 17 (54.8)
Facial asymmetry 
(N = 26)
No 0 23 (88.5)
Yes 1 3 (11.5)
Absent or Abnormal 
Ribsc (N = 25)
No 0 18 (72)




No 0 11 (52.3)
Yes 1 10 (47.6)123
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random XCI. In addition, there was extremely skewed XCI
in one mother–daughter pair (Fig. 1b). Our current data do
not reXect a signiWcant correlation between age and per-
centage of XCI in the girls with Aicardi syndrome
(R = ¡0.12; p = 0.25) (data not shown). This may be
related to sample size, the young age and the limited age
range of our study population (0.25–16.42 years).
For nine girls with skewed or extremely skewed XCI for
when we could determine the parental origin of the prefer-
entially inactivated X-chromosome, we found that the
paternal X and the maternal X were equally likely to be
preferentially inactivated with the paternal X inactivated in
Wve (55%) versus the maternal X inactivated in four (45%)
girls.
To evaluate whether skewing of XCI was associated
with severity of the phenotype, we scored key distinctive
features of AIC (Table 1) for severity and derived an over-
all, neurological, skeletal and ophthalmological composite
severity scores (CSS) (Table 2). We then compared the
severity of individual features and the composite severity
scores between the groups with random and non-random
XCI patterns. For the individual features we found a statis-
tically signiWcant association between the presence of
vertebral abnormalities and a random pattern of XCI
(p = 0.05). We also found that girls with non-random XCI
had a higher mean neurological composite severity score
compared to girls with random XCI (p = 0.049) but a lower
mean skeletal composite severity score compared to girls
with random XCI (p = 0.05). There was no association
between the degree of skewing and overall or ophthalmo-
logical severity scores, but this may reXect the essential role
of the ophthalmological features in the diagnosis of AIC.
The clinical signiWcance of these correlations is currently
unclear.
Discussion
It is thought that Aicardi syndrome is caused by the muta-
tion of a gene or genes on the X-chromosome that are sub-
ject to XCI because it is sporadic and occurs exclusively in
females or rare males with two X chromosomes (47,XXY
karyotype). Studies of XCI in AIC conducted in the past
Fig. 1 Patterns of X chromosome inactivation in girls with Aicardi
syndrome and their mothers. The % XCI is shown for each AIC girl (a)
and for mother-girl pairs (b). a includes only 33 bars because two of
the 35 girls tested had non-informative results. Twenty-Wve mother-
girl pairs for which informative results were available for both mother
and daughter are included in b. The active % of one versus the other
X-chromosome is represented as black-and-white vertical bars for
AIC girls and as black-and-grey vertical bars for mothers. The areas
on the graphs below the hatched line delineate the 80:20% cut oV for
skewing. Asterisks indicate pairs in which the mother has skewed XCI
while the daughter has random XCI. Dagger indicates a pair in which
both mother and daughter have extremely skewed XCI
Table 2 Correlation of XCI with severity of the AIC phenotype
Mean scores for each CSS were calculated by averaging the number of
scored features observed in each participant. P values are from the
Wilcoxon rank test. Two types of correlations with overall CSS were
preformed
a Includes only patients with values for each one of the phenotypes
examined






XCI (n = 23)
Mean CSS 
non-random 











Skeletal (N = 19) 1.0 0.3 0.05
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some inactivation status in AIC (Neidich et al. 1990; Hoag
et al. 1997; Wieacker et al. 1985). Our study demonstrates
that skewing of XCI is present in a much higher number of
aVected girls than what would be expected, even though not
all subjects have non-random patterns of XCI.
Dosage compensation for genes on the X-chromosome
between females having two X-chromosomes and males
having one X-chromosome is achieved through the mecha-
nism of XCI (Migeon 1994). In females, most genes on one
of the two X-chromosomes in each somatic cell are inacti-
vated during early embryogenesis (Bittel et al. 2008). When
somatic cells divide, the choice of which X is inactivated is
passed on to subsequent daughter cells and the result should
be an approximately equal distribution of cells with mater-
nally and paternally inherited X-chromosomes inactive. The
fraction of cells that inactivate either the maternally or pater-
nally inherited X-chromosome follows a normal distribution
in the general population. When DNA from peripheral blood
cells is analyzed, extreme skewing (>95:5%) occurs in »1%
of females (Bittel et al. 2008; Amos-Landgraf et al. 2006;
Hatakeyama et al. 2004; Sharp et al. 2000) while overall
skewing (>80:20%) occurs in »8% of females (Amos-
Landgraf et al. 2006). In contrast, our study showed that 33%
of girls with Aicardi syndrome had skewed XCI and 18%
had extremely skewed XCI. Although our study was done on
a diVerent set of DNA samples than prior reports of XCI pat-
terns in the general population, the method and tissues used
to evaluate XCI was similar. Hence, we conclude that the
prevalence of extremely skewed XCI is higher than in the
general population. This supports the prevailing hypothesis
that AIC is due to a mutation in a gene on the X-chromosome
that is subject to XCI. Similarly, an increased prevalence of
skewing is seen incontinentia pigmenti, a condition that is
X-linked and lethal in males (Wieacker et al. 1985; Parrish
et al. 1996). Selection against cells with an active mutation-
bearing chromosome has also been observed in female carri-
ers of certain X-linked immunodeWciencies, such as X-linked
agammaglobulinemia and X-linked severe combined immu-
nodeWciency (Puck and Willard 1998).
There are various plausible explanations for the fact that
not all individuals with Aicardi syndrome have extremely
skewed or skewed XCI. Some may have milder mutations in
the putative gene. Another explanation could be the presence
of postzygotic mosaic mutations, as has been recently sug-
gested to explain random XCI in another X-linked dominant
disorder, Goltz syndrome (Grzeschik et al. 2007). Although
conWrmation will need to await discovery of the causative
gene, it could explain why 67% of girls with AIC have ran-
dom XCI, and might account for the wide range of pheno-
types seen in aVected girls. Another explanation for the
observed random XCI in 67% of subjects could be the eVect
of age on patterns of XCI in rapidly renewing cells, such as
peripheral blood leukocytes. This is observed in Wiscott–
Aldrich syndrome, where there is a post-inactivation
disadvantage to cells that have the mutation-bearing X-chro-
mosome active in women who carry heterozygous WAS
mutations (Puck and Willard 1998). Although we may have
underestimated the frequency of skewing in some of the girls
with AIC for this reason, it is less likely because we are
studying a very young population (mean age 5.12 years).
Typically an increased frequency of skewed XCI is seen in
the general population in women 60 years of age and older
(Sharp et al. 2000).
Girls with skewed XCI were found to have signiWcantly
more severe neurological involvement than girls with ran-
dom XCI. Conversely, girls with random XCI were found
to be signiWcantly more likely to have vertebral anomalies
and a greater overall skeletal involvement. The clinical
relevance of these observations will remain unclear until
the disease-causing gene is identiWed.
The possibility of a mutation on an autosome with sex-
limited expression rather than an X-linked mutation can
theoretically not be completely eliminated as a possible
cause of AIC, but the departure from the non-random XCI
in our larger cohort of individuals with AIC provides addi-
tional strong evidence that it is due to a mutation in an
X-linked gene that is subject to XCI and reinforces the
approach to focus the search for an appropriate candidate
gene to the X chromosome. Because our study was per-
formed on DNA from peripheral blood leukocytes, our
results may further suggest that the putative AIC gene has a
function in peripheral blood leukocytes or bone marrow
cells, even though the phenotype is primarily neurological
and ocular. Our combined Wndings will aid prioritization of
candidate genes for ongoing mutation analysis studies.
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